{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:36:38Z","timestamp":1785458198214,"version":"3.56.0"},"publisher-location":"New York, NY","reference-count":66,"publisher":"Springer US","isbn-type":[{"value":"9781071635223","type":"print"},{"value":"9781071635230","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T00:00:00Z","timestamp":1702080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T00:00:00Z","timestamp":1702080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-1-0716-3523-0_14","type":"book-chapter","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T19:02:16Z","timestamp":1702062136000},"page":"207-235","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["A Review of Phage Therapy for Bone and Joint Infections"],"prefix":"10.1007","author":[{"given":"Tristan","family":"Ferry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,9]]},"reference":[{"key":"14_CR1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1128\/AAC.45.3.649-659.2001","volume":"45","author":"A Sulakvelidze","year":"2001","unstructured":"Sulakvelidze A, Alavidze Z, Morris JG (2001) Bacteriophage therapy. Antimicrob Agents Chemother 45:649\u2013659","journal-title":"Antimicrob Agents Chemother"},{"key":"14_CR2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.chom.2019.01.009","volume":"25","author":"JT Rost\u00f8l","year":"2019","unstructured":"Rost\u00f8l JT, Marraffini L (2019) (Ph)ighting phages: how bacteria resist their parasites. Cell Host Microbe 25:184\u2013194","journal-title":"Cell Host Microbe"},{"key":"14_CR3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00705-006-0849-1","volume":"152","author":"H-W Ackermann","year":"2007","unstructured":"Ackermann H-W (2007) 5500 phages examined in the electron microscope. Arch Virol 152:227\u2013243","journal-title":"Arch Virol"},{"key":"14_CR4","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.3390\/v13122414","volume":"13","author":"T Ferry","year":"2021","unstructured":"Ferry T, Kolenda C, Briot T et al (2021) Past and future of phage therapy and phage-derived proteins in patients with bone and joint infection. Viruses 13:2414","journal-title":"Viruses"},{"key":"14_CR5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fcimb.2019.00022","volume":"9","author":"TL Tagliaferri","year":"2019","unstructured":"Tagliaferri TL, Jansen M, Horz H-P (2019) Fighting pathogenic bacteria on two fronts: phages and antibiotics as combined strategy. Front Cell Infect Microbiol 9:22","journal-title":"Front Cell Infect Microbiol"},{"key":"14_CR6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0140-6736(04)16727-5","volume":"364","author":"DP Lew","year":"2004","unstructured":"Lew DP, Waldvogel FA (2004) Osteomyelitis. Lancet 364:369\u2013379","journal-title":"Lancet"},{"key":"14_CR7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1302\/2046-3758.910.BJR-2019-0362.R1","volume":"9","author":"A Lemaignen","year":"2020","unstructured":"Lemaignen A, Grammatico-Guillon L, Astagneau P et al (2020) Computerized registry as a potential tool for surveillance and management of complex bone and joint infections in France: French registry of complex bone and joint infections. Bone Joint Res 9:635\u2013644","journal-title":"Bone Joint Res"},{"key":"14_CR8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.otsr.2018.09.016","volume":"105","author":"T Ferry","year":"2019","unstructured":"Ferry T, Seng P, Mainard D et al (2019) The CRIOAc healthcare network in France: a nationwide health ministry program to improve the management of bone and joint infection. Orthop Traumatol Surg Res 105:185\u2013190","journal-title":"Orthop Traumatol Surg Res"},{"key":"14_CR9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cmi.2021.09.027","volume":"28","author":"T Ferry","year":"2022","unstructured":"Ferry T, Kolenda C, Briot T et al (2022) Implementation of a complex bone and joint infection phage therapy centre in France: lessons to be learned after 4 years\u2019 experience. Clin Microbiol Infect 28:145\u2013146","journal-title":"Clin Microbiol Infect"},{"key":"14_CR10","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.cmi.2019.08.006","volume":"26","author":"M Depypere","year":"2020","unstructured":"Depypere M, Morgenstern M, Kuehl R et al (2020) Pathogenesis and management of fracture-related infection. Clin Microbiol Infect 26:572\u2013578","journal-title":"Clin Microbiol Infect"},{"key":"14_CR11","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMra040181","volume":"351","author":"W Zimmerli","year":"2004","unstructured":"Zimmerli W, Trampuz A, Ochsner PE (2004) Prosthetic-joint infections. N Engl J Med 351:1645\u20131654","journal-title":"N Engl J Med"},{"key":"14_CR12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12879-018-3076-y","volume":"18","author":"J Andrianasolo","year":"2018","unstructured":"Andrianasolo J, Ferry T, Boucher F et al (2018) Pressure ulcer-related pelvic osteomyelitis: evaluation of a two-stage surgical strategy (debridement, negative pressure therapy and flap coverage) with prolonged antimicrobial therapy. BMC Infect Dis 18:166","journal-title":"BMC Infect Dis"},{"key":"14_CR13","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJMra1213956","volume":"370","author":"H Peltola","year":"2014","unstructured":"Peltola H, P\u00e4\u00e4kk\u00f6nen M (2014) Acute osteomyelitis in children. N Engl J Med 370:352\u2013360","journal-title":"N Engl J Med"},{"key":"14_CR14","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/CMR.00111-13","volume":"27","author":"AJ Tande","year":"2014","unstructured":"Tande AJ, Patel R (2014) Prosthetic joint infection. Clin Microbiol Rev 27:302\u2013345","journal-title":"Clin Microbiol Rev"},{"key":"14_CR15","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.tim.2013.06.002","volume":"21","author":"T Bjarnsholt","year":"2013","unstructured":"Bjarnsholt T, Alhede M, Alhede M et al (2013) The in vivo biofilm. Trends Microbiol 21:466\u2013474","journal-title":"Trends Microbiol"},{"key":"14_CR16","doi-asserted-by":"crossref","first-page":"bcr2014209169","DOI":"10.1136\/bcr-2014-209169","volume":"2015","author":"E Virot","year":"2015","unstructured":"Virot E, Servien E, Laurent F et al (2015) Reactivation of Clostridium tertium bone infection 30\u00a0years after the Iran-Iraq war. BMJ Case Rep 2015:bcr2014209169","journal-title":"BMJ Case Rep"},{"key":"14_CR17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/apm.12687","volume":"125","author":"W Zimmerli","year":"2017","unstructured":"Zimmerli W, Sendi P (2017) Orthopaedic biofilm infections. APMIS 125:353\u2013364","journal-title":"APMIS"},{"key":"14_CR18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1051\/sicotj\/2020021","volume":"6","author":"T Ferry","year":"2020","unstructured":"Ferry T, Batailler C, Brosset S et al (2020) Medical innovations to maintain the function in patients with chronic PJI for whom explantation is not desirable: a pathophysiology-, multidisciplinary-, and experience-based approach. SICOT J 6:26","journal-title":"SICOT J"},{"key":"14_CR19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/jor.20003","volume":"24","author":"JK Ellington","year":"2006","unstructured":"Ellington JK, Harris M, Hudson MC et al (2006) Intracellular Staphylococcus aureus and antibiotic resistance: implications for treatment of staphylococcal osteomyelitis. J Orthop Res 24:87\u201393","journal-title":"J Orthop Res"},{"key":"14_CR20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.biologicals.2019.10.003","volume":"63","author":"M Adnan","year":"2020","unstructured":"Adnan M, Ali Shah MR, Jamal M et al (2020) Isolation and characterization of bacteriophage to control multidrug-resistant Pseudomonas aeruginosa planktonic cells and biofilm. Biologicals 63:89\u201396","journal-title":"Biologicals"},{"key":"14_CR21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/NSA.S325594","volume":"14","author":"S Amankwah","year":"2021","unstructured":"Amankwah S, Abdusemed K, Kassa T (2021) Bacterial biofilm destruction: a focused review on the recent use of phage-based strategies with other antibiofilm agents. Nanotechnol Sci Appl 14:161\u2013177","journal-title":"Nanotechnol Sci Appl"},{"key":"14_CR22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12941-020-00389-5","volume":"19","author":"Z Chegini","year":"2020","unstructured":"Chegini Z, Khoshbayan A, Taati Moghadam M et al (2020) Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review. Ann Clin Microbiol Antimicrob 19:45","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"14_CR23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/antibiotics10020175","volume":"10","author":"G Topka-Bielecka","year":"2021","unstructured":"Topka-Bielecka G, Dydecka A, Necel A et al (2021) Bacteriophage-derived depolymerases against bacterial biofilm. Antibiotics (Basel) 10:175","journal-title":"Antibiotics (Basel)"},{"key":"14_CR24","doi-asserted-by":"crossref","first-page":"105322","DOI":"10.1016\/j.bioorg.2021.105322","volume":"116","author":"H Lu","year":"2021","unstructured":"Lu H, Xiong W, Li Z et al (2021) Activity of the lyases LysSSE1 and HolSSE1 against common pathogenic bacteria and their antimicrobial efficacy in biofilms. Bioorg Chem 116:105322","journal-title":"Bioorg Chem"},{"key":"14_CR25","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00588-22","volume":"66","author":"A Souche","year":"2022","unstructured":"Souche A, Kolenda C, Teoli J et al (2022) Activity of Exebacase (CF-301) against biofilms formed by Staphylococcus epidermidis strains isolated from prosthetic joint infections. Antimicrob Agents Chemother 66:e0058822","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 3","key":"14_CR26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.injury.2019.06.018","volume":"50","author":"TF Raven","year":"2019","unstructured":"Raven TF, Moghaddam A, Ermisch C et al (2019) Use of Masquelet technique in treatment of septic and atrophic fracture nonunion. Injury 50(Suppl 3):40\u201354","journal-title":"Injury"},{"key":"14_CR27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0736-0266(03)00165-7","volume":"22","author":"P Pelissier","year":"2004","unstructured":"Pelissier P, Masquelet AC, Bareille R et al (2004) Induced membranes secrete growth factors including vascular and osteoinductive factors and could stimulate bone regeneration. J Orthop Res 22:73\u201379","journal-title":"J Orthop Res"},{"key":"14_CR28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.7150\/jbji.17234","volume":"2","author":"J Ferguson","year":"2017","unstructured":"Ferguson J, Diefenbeck M, McNally M (2017) Ceramic biocomposites as biodegradable antibiotic carriers in the treatment of bone infections. J Bone Jt Infect 2:38\u201351","journal-title":"J Bone Jt Infect"},{"key":"14_CR29","doi-asserted-by":"crossref","first-page":"919","DOI":"10.5312\/wjo.v6.i11.919","volume":"6","author":"D Ramanathan","year":"2015","unstructured":"Ramanathan D, Siqueira MB, Klika AK et al (2015) Current concepts in total femoral replacement. World J Orthop 6:919\u2013926","journal-title":"World J Orthop"},{"key":"14_CR30","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cis803","volume":"56","author":"DR Osmon","year":"2013","unstructured":"Osmon DR, Berbari EF, Berendt AR et al (2013) Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 56:e1\u2013e25","journal-title":"Clin Infect Dis"},{"key":"14_CR31","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0891-5520(02)00016-8","volume":"16","author":"V Kak","year":"2002","unstructured":"Kak V, Chandrasekar PH (2002) Bone and joint infections in injection drug users. Infect Dis Clin N Am 16:681\u2013695","journal-title":"Infect Dis Clin N Am"},{"key":"14_CR32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.diabet.2007.09.005","volume":"34","author":"A Hartemann-Heurtier","year":"2008","unstructured":"Hartemann-Heurtier A, Senneville E (2008) Diabetic foot osteomyelitis. Diabetes Metab 34:87\u201395","journal-title":"Diabetes Metab"},{"issue":"Suppl 3","key":"14_CR33","first-page":"iii11","volume":"65","author":"T Gouliouris","year":"2010","unstructured":"Gouliouris T, Aliyu SH, Brown NM (2010) Spondylodiscitis: update on diagnosis and management. J Antimicrob Chemother 65(Suppl 3):iii11\u2013iii24","journal-title":"J Antimicrob Chemother"},{"key":"14_CR34","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1093\/cid\/civ482","volume":"61","author":"EF Berbari","year":"2015","unstructured":"Berbari EF, Kanj SS, Kowalski TJ et al (2015) 2015 Infectious Diseases Society of America (IDSA) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults. Clin Infect Dis 61:e26\u2013e46","journal-title":"Clin Infect Dis"},{"key":"14_CR35","first-page":"317","volume":"32","author":"S Slopek","year":"1984","unstructured":"Slopek S, Durlakowa I, Weber-Dabrowska B et al (1984) Results of bacteriophage treatment of suppurative bacterial infections. III. Detailed evaluation of the results obtained in further 150 cases. Arch Immunol Ther Exp 32:317\u2013335","journal-title":"Arch Immunol Ther Exp"},{"key":"14_CR36","volume-title":"Le Bact\u00e9riophage et ses applications th\u00e9rapeutiques","author":"A Raiga","year":"1932","unstructured":"Raiga A (1932) Le Bact\u00e9riophage et ses applications th\u00e9rapeutiques. La Science M\u00e9dicale Pratique, Paris"},{"key":"14_CR37","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12250-014-3557-0","volume":"30","author":"M Kutateladze","year":"2015","unstructured":"Kutateladze M (2015) Experience of the Eliava institute in bacteriophage therapy. Virol Sin 30:80\u201381","journal-title":"Virol Sin"},{"key":"14_CR38","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10238-009-0044-2","volume":"9","author":"R Miedzybrodzki","year":"2009","unstructured":"Miedzybrodzki R, Fortuna W, Weber-Dabrowska B, G\u00f3rski A (2009) A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses. Clin Exp Med 9:303\u2013312","journal-title":"Clin Exp Med"},{"key":"14_CR39","doi-asserted-by":"crossref","first-page":"ofy269","DOI":"10.1093\/ofid\/ofy269","volume":"5","author":"T Ferry","year":"2018","unstructured":"Ferry T, Leboucher G, Fevre C et al (2018) Salvage Debridement, Antibiotics and Implant Retention (\u201cDAIR\u201d) with local injection of a selected cocktail of bacteriophages: is it an option for an elderly patient with relapsing Staphylococcus aureus prosthetic-joint infection? Open Forum Infect Dis 5:ofy269","journal-title":"Open Forum Infect Dis"},{"key":"14_CR40","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1093\/jac\/dky263","volume":"73","author":"T Ferry","year":"2018","unstructured":"Ferry T, Boucher F, Fevre C et al (2018) Innovations for the treatment of a complex bone and joint infection due to XDR Pseudomonas aeruginosa including local application of a selected cocktail of bacteriophages. J Antimicrob Chemother 73:2901\u20132903","journal-title":"J Antimicrob Chemother"},{"key":"14_CR41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/jam.2006.19.47","volume":"19","author":"I Gonda","year":"2006","unstructured":"Gonda I (2006) Systemic delivery of drugs to humans via inhalation. J Aerosol Med 19:47\u201353","journal-title":"J Aerosol Med"},{"key":"14_CR42","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1080\/10837450.2018.1484766","volume":"23","author":"TJ Purohit","year":"2018","unstructured":"Purohit TJ, Hanning SM, Wu Z (2018) Advances in rectal drug delivery systems. Pharm Dev Technol 23:942\u2013952","journal-title":"Pharm Dev Technol"},{"issue":"22","key":"14_CR43","first-page":"00283","volume":"S0168-3659","author":"T Briot","year":"2022","unstructured":"Briot T, Kolenda C, Ferry T et al (2022) Paving the way for phage therapy using novel drug delivery approaches. J Control Release S0168-3659(22):00283\u201300288","journal-title":"J Control Release"},{"key":"14_CR44","doi-asserted-by":"crossref","first-page":"e00012","DOI":"10.1128\/MMBR.00012-19","volume":"83","author":"K D\u0105browska","year":"2019","unstructured":"D\u0105browska K, Abedon ST (2019) Pharmacologically aware phage therapy: pharmacodynamic and pharmacokinetic obstacles to phage antibacterial action in animal and human bodies. Microbiol Mol Biol Rev 83:e00012\u2013e00019","journal-title":"Microbiol Mol Biol Rev"},{"key":"14_CR45","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3390\/v11100891","volume":"11","author":"J Onsea","year":"2019","unstructured":"Onsea J, Soentjens P, Djebara S et al (2019) Bacteriophage application for difficult-to-treat musculoskeletal infections: development of a standardized multidisciplinary treatment protocol. Viruses 11:891","journal-title":"Viruses"},{"key":"14_CR46","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cis.2017.05.014","volume":"249","author":"DJ Malik","year":"2017","unstructured":"Malik DJ, Sokolov IJ, Vinner GK et al (2017) Formulation, stabilisation and encapsulation of bacteriophage for phage therapy. Adv Colloid Interf Sci 249:100\u2013133","journal-title":"Adv Colloid Interf Sci"},{"key":"14_CR47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.22203\/eCM.v039a13","volume":"39","author":"J Onsea","year":"2020","unstructured":"Onsea J, Wagemans J, Pirnay JP et al (2020) Bacteriophage therapy as a treatment strategy for orthopaedic-device-related infections: where do we stand? Eur Cell Mater 39:193\u2013210","journal-title":"Eur Cell Mater"},{"key":"14_CR48","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/vim.2013.0128","volume":"27","author":"M \u0141usiak-Szelachowska","year":"2014","unstructured":"\u0141usiak-Szelachowska M, Zaczek M, Weber-D\u0105browska B et al (2014) Phage neutralization by sera of patients receiving phage therapy. Viral Immunol 27:295\u2013304","journal-title":"Viral Immunol"},{"key":"14_CR49","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2217\/fmb-2017-0049","volume":"12","author":"A G\u00f3rski","year":"2017","unstructured":"G\u00f3rski A, D\u0105browska K, Mi\u0119dzybrodzki R et al (2017) Phages and immunomodulation. Future Microbiol 12:905\u2013914","journal-title":"Future Microbiol"},{"key":"14_CR50","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1086\/522184","volume":"45","author":"EF Berbari","year":"2007","unstructured":"Berbari EF, Marculescu C, Sia I et al (2007) Culture-negative prosthetic joint infection. Clin Infect Dis 45:1113\u20131119","journal-title":"Clin Infect Dis"},{"key":"14_CR51","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/s11999-010-1338-0","volume":"468","author":"D Malekzadeh","year":"2010","unstructured":"Malekzadeh D, Osmon DR, Lahr BD et al (2010) Prior use of antimicrobial therapy is a risk factor for culture-negative prosthetic joint infection. Clin Orthop Relat Res 468:2039\u20132045","journal-title":"Clin Orthop Relat Res"},{"key":"14_CR52","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/jpids\/pis108","volume":"2","author":"M P\u00e4\u00e4kk\u00f6nen","year":"2013","unstructured":"P\u00e4\u00e4kk\u00f6nen M, Kallio MJT, Kallio PE, Peltola H (2013) Significance of negative cultures in the treatment of acute hematogenous bone and joint infections in children. J Pediatric Infect Dis Soc 2:119\u2013125","journal-title":"J Pediatric Infect Dis Soc"},{"key":"14_CR53","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-1-4939-7395-8_13","volume":"1693","author":"VV Morozova","year":"2018","unstructured":"Morozova VV, Kozlova YN, Ganichev DA, Tikunova NV (2018) Bacteriophage treatment of infected diabetic foot ulcers. Methods Mol Biol 1693:151\u2013158","journal-title":"Methods Mol Biol"},{"key":"14_CR54","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1302\/2046-3758.59.BJR-2016-0108.R1","volume":"5","author":"M Stravinskas","year":"2016","unstructured":"Stravinskas M, Horstmann P, Ferguson J et al (2016) Pharmacokinetics of gentamicin eluted from a regenerating bone graft substitute: in vitro and clinical release studies. Bone Joint Res 5:427\u2013435","journal-title":"Bone Joint Res"},{"key":"14_CR55","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01736-21","volume":"9","author":"J Onsea","year":"2021","unstructured":"Onsea J, Post V, Buchholz T et al (2021) Bacteriophage therapy for the prevention and treatment of fracture-related infection caused by Staphylococcus aureus: a preclinical study. Microbiol Spectr 9:e0173621","journal-title":"Microbiol Spectr"},{"key":"14_CR56","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/cid\/ciz222","volume":"69","author":"R Nir-Paz","year":"2019","unstructured":"Nir-Paz R, Gelman D, Khouri A et al (2019) Successful treatment of antibiotic-resistant, poly-microbial bone infection with bacteriophages and antibiotics combination. Clin Infect Dis 69:2015\u20132018","journal-title":"Clin Infect Dis"},{"key":"14_CR57","first-page":"1064","volume":"1","author":"L Sarr","year":"2018","unstructured":"Sarr L, Demb\u00e9l\u00e9 B, Mouhamed D et al (2018) Chronic pandiaphysity with chronic osteomyelitis. SM J Orthop 1:1064","journal-title":"SM J Orthop"},{"key":"14_CR58","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF02716217","volume":"5","author":"HC Pape","year":"1995","unstructured":"Pape HC, Zwipp H, Regel G et al (1995) Chronic diaphyseal osteomyelitis of long bones refractory to conventional therapy \u2013 benefits and risks of reaming of the femoral medullary cavity. Eur J Orthop Surg Traumatol 5:53\u201358","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"14_CR59","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/v11030265","volume":"11","author":"S Djebara","year":"2019","unstructured":"Djebara S, Maussen C, De Vos D et al (2019) Processing phage therapy requests in a Brussels military hospital: lessons identified. Viruses 11:265","journal-title":"Viruses"},{"key":"14_CR60","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association (2013) World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310:2191\u20132194","journal-title":"JAMA"},{"key":"14_CR61","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1038\/s41467-022-31837-9","volume":"13","author":"T Ferry","year":"2022","unstructured":"Ferry T, Kolenda C, Laurent F et al (2022) Personalized bacteriophage therapy to treat pandrug-resistant spinal Pseudomonas aeruginosa infection. Nat Commun 13:4239","journal-title":"Nat Commun"},{"key":"14_CR62","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1093\/cid\/ciaa705","volume":"73","author":"EJ Cano","year":"2021","unstructured":"Cano EJ, Caflisch KM, Bollyky PL et al (2021) Phage therapy for limb-threatening prosthetic knee Klebsiella pneumoniae infection: case report and in vitro characterization of anti-biofilm activity. Clin Infect Dis 73:e144\u2013e151","journal-title":"Clin Infect Dis"},{"issue":"3","key":"14_CR63","doi-asserted-by":"publisher","first-page":"e1463","DOI":"10.1093\/cid\/ciac694","volume":"76","author":"JB Doub","year":"2023","unstructured":"Doub JB, Johnson AJ, Nandi S et al (2023) Experience using adjuvant bacteriophage therapy for the treatment of 10 recalcitrant periprosthetic joint infections: a case series. Clin Infect Dis 76(3):e1463\u2013e1466. https:\/\/doi.org\/10.1093\/cid\/ciac694","journal-title":"Clin Infect Dis"},{"key":"14_CR64","unstructured":"Ferry T, Kolenda C, Briot T, et al. (2021) Implementation of a complex bone and joint infection phage therapy centre in France: lessons to be learned after 4 years\u2019 experience. Clin Microbiol Infect S1198-743X(21)00556\u20135"},{"key":"14_CR65","doi-asserted-by":"crossref","first-page":"570572","DOI":"10.3389\/fmed.2020.570572","volume":"7","author":"T Ferry","year":"2020","unstructured":"Ferry T, Kolenda C, Batailler C et al (2020) Phage therapy as adjuvant to conservative surgery and antibiotics to salvage patients with relapsing S. Aureus prosthetic knee infection. Front Med 7:570572","journal-title":"Front Med"},{"key":"14_CR66","doi-asserted-by":"crossref","first-page":"569159","DOI":"10.3389\/fmed.2021.569159","volume":"8","author":"T Ferry","year":"2021","unstructured":"Ferry T, Kolenda C, Batailler C et al (2021) Case report: arthroscopic \u201cdebridement antibiotics and implant retention\u201d with local injection of personalized phage therapy to salvage a relapsing Pseudomonas aeruginosa prosthetic knee infection. Front Med (Lausanne) 8:569159","journal-title":"Front Med (Lausanne)"}],"container-title":["Methods in Molecular Biology","Bacteriophage Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3523-0_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T10:06:25Z","timestamp":1704708385000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3523-0_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,9]]},"ISBN":["9781071635223","9781071635230"],"references-count":66,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3523-0_14","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,9]]},"assertion":[{"value":"9 December 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}